Clinical Application Effects of Different Preoperative Blood Management Schemes in Older Patients with Delayed Intertrochanteric Fracture Surgery
Yu Cui,Yao Lu,Qiang Huang,Congming Zhang,Liang Sun,Cheng Ren,Qian Wang,Teng Ma,Zhong Li,Kun Zhang,Zhimeng Wang,Hanzhong Xue
DOI: https://doi.org/10.2147/CIA.S362020
IF: 3.829
2022-05-20
Clinical Interventions in Aging
Abstract:Yu Cui, &ast Yao Lu, &ast Qiang Huang, Congming Zhang, Liang Sun, Cheng Ren, Qian Wang, Teng Ma, Zhong Li, Kun Zhang, Zhimeng Wang, Hanzhong Xue Department of Orthopedics and Trauma, Hong Hui Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi, 710000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhimeng Wang; Hanzhong Xue, Department of Orthopedics and Trauma, Hong Hui Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi, 710000, People's Republic of China, Email ; Introduction: Research on preoperative blood management in older patients with delayed surgery for intertrochanteric fracture is scarce, especially regarding hematopoiesis and hemostasis. We assessed the effectiveness of optimized blood management programs in older patients undergoing delayed surgery for intertrochanteric fractures. Methods: This retrospective study included 456 patients who underwent delayed surgery for intertrochanteric fractures. According to the optimized blood management plan, the patients were divided into four groups: group A was the control group; group B received 1 g of tranexamic acid (TXA) intravenously at admission; group C underwent sequential TXA treatment after admission until 1 day before surgery (1 g/day); and group D received iron supplements (200 mg/day) in addition to the treatment administered to group C, with or without recombinant human erythropoietin (rHuEPO; 40,000 IU). The primary outcomes were preoperative hidden blood loss (HBL), preoperative allogeneic blood transfusion (ABT) rate, hemoglobin (Hb) change, and actual Hb drop. Results: The Hb reduction, calculated HBL, and hospitalization duration in groups C and D were significantly lower than those in groups A and B. The preoperative ABT rates in groups C and D were significantly lower than those in groups A and B, with no significant difference between groups C and D. Discussion: The results of this study suggested that iron supplementation (with or without rHuEPO) combined with the sequential IV TXA scheme did not show a better clinical effect than the sequential IV TXA scheme in the management of patients undergoing delayed surgery for intertrochanteric fractures. Therefore, further evaluation is needed before recommending iron supplements and rHuEPO in older patients. Keywords: blood management, iron supplements, surgical delay, intertrochanteric fractures, tranexamic acid Owing to its large and rapidly aging population, China has the largest number of older people worldwide. Hip fractures have become a public health concern owing to their poor prognosis; thus, China is currently facing great challenges due to an increasing number of patients with hip fractures. 1,2 A systematic analysis reported 1-year mortality rates after hip fracture and intertrochanteric fracture (IF) in China of 13.96% and 17.47%, 3 respectively. Perioperative anemia is an important factor for mortality after hip fracture surgery and is closely related to the fracture type, such as intracapsular or extracapsular. 4,5 Acute post-traumatic anemia and the need for transfusion in older patients with IFs are the major concerns for orthopedic surgeons. Pre-anemia increases the severity and incidence of postoperative anemia and increases the need for blood transfusion. 6 Therefore, an ideal blood management program should include an attempt to minimize preoperative blood loss and to correct preoperative anemia. 7 Post-traumatic hyperfibrinolysis is one of the most important causes of preoperative blood loss, and the administration of anti-fibrinolytic drugs is an effective treatment to reduce hidden blood loss (HBL). 8 Previous studies have focused on tranexamic acid (TXA) to reduce intraoperative and postoperative hemorrhage in IFs; 9–11 however, studies on occult hemorrhage before the operation are limited. 12 Intravenous (IV) iron supplementation, with or without recombinant human erythropoietin (rHuEPO) therapy, has been proposed as an intervention to correct preoperative anemia. 13 However, the actual clinical effects remain controversial. 14,15 Strong evidence is lacking to support the preoperative clinical benefit of iron supplements and rHuEPO in older patients with IFs. Over the past 8 years, we have been committed to perioperative blood management for older patients with hip fractures. Within this patient population, this study focuses on the management of patients undergoing delayed surgery for IFs. We have adopted a variety of intervention programs, including the administration of TXA, iron, and rHuEPO; however, the clinical effects of different application -Abstract Truncated-
geriatrics & gerontology,gerontology